S100A9 and inflammation: In conclusion, the results of this study suggest that S100A9 may play a pivotal role in NA by enhancing neutrophil activation, NET formation, and macrophage polarization, and S100A9 is a therapeutic target of neutrophilic airway inflammation, especially in patients with SA.